Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up

Open access
Odekerken, Vincent J.J., Boel, Judith A., Schmand, Ben A., de Haan, Rob J., Figee, M., van den Munckhof, Pepijn, Schuurman, P. Richard, de Bie, Rob M.A., For the NSTAPS study group, NSTAPS study group, de Bie, R.M.A., Bour, L., Contarino, M.F., de Haan, R.J., Iwan, M., Mink, M.S.J., van den Munckhof, P., Odekerken, V.J.J., Postma, M., Schmand, B.A., Scholten, M.N., Schuurman, P.R., van Laar, T., van Dijk, J.M.C., Hoffmann, C.F.E., Mosch, A., Beute, G.N., Nijssen, P.C.G., van Asseldonk, T., Lenders, M.W.P.M., van Vugt, J.P.P. · 2016 · Neurology

Abstract

OBJECTIVE: To compare motor symptoms, cognition, mood, and behavior 3 years after deep brain stimulation (DBS) of the globus pallidus pars interna (GPi) and subthalamic nucleus (STN) in advanced Parkinson disease (PD). METHODS: Patients with PD eligible for DBS were randomized to bilateral GPi DBS and bilateral STN DBS (1:1). The primary outcome measures were (1) improvement in motor symptoms in off-drug phase measured with the Unified Parkinson Disease Rating Scale (UPDRS) and (2) a composite score for cognitive, mood, and behavioral effects, and inability to complete follow-up at 36 months after surgery. RESULTS: Of the 128 patients enrolled, 90 were able to complete the 3-year follow-up. We found significantly more improvement of motor symptoms after STN DBS (median [interquartile range (IQR)] at 3 years, GPi 33 [23-41], STN 28 [20-36], p = 0.04). No between-group differences were observed on the composite score (GPi 83%, STN 86%). Secondary outcomes showed larger improvement in off-drug functioning in the AMC Linear Disability Scale score after STN DBS (mean ± SD, GPi 65.2 ± 20.1, STN 72.6 ± 18.0, p = 0.05). Medication was reduced more after STN DBS (median levodopa equivalent dose [IQR] at 3 years, GPi 1,060 [657-1,860], STN 605 [411-875], p < 0.001). No differences in adverse effects were recorded, apart from more reoperations to a different target after GPi DBS (GPi n = 8, STN n = 1). CONCLUSIONS: Off-drug phase motor symptoms and functioning improve more after STN DBS than after GPi DBS. No between-group differences were observed on a composite score for cognition, mood, and behavior, and the inability to participate in follow-up. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that STN DBS provides more off-phase motor improvement than GPi DBS, but with a similar risk for cognitive, mood, and behavioral complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000002401

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 251

Metadata

Authors
Odekerken, V. J. J., Boel, J. A., Schmand, B. A., de Haan, R. J., Figee, M., van den Munckhof, P., Schuurman, P. R., de Bie, R. M. A., For the NSTAPS study group, NSTAPS study group, de Bie, R. M. A., Bour, L., Contarino, M. F., de Haan, R. J., Iwan, M., Mink, M. S. J., van den Munckhof, P., Odekerken, V. J. J., Postma, M., Schmand, B. A., Scholten, M. N., Schuurman, P. R., van Laar, T., van Dijk, J. M. C., Hoffmann, C. F. E., Mosch, A., Beute, G. N., Nijssen, P. C. G., van Asseldonk, T., Lenders, M. W. P. M., & van Vugt, J. P. P.
Venue
Neurology
Published
2016-02-23
Volume
86
Issue
8
Pages
755-761
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2329059023
Cited by
251
References
4
FWCI
17.59
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up. https://app.cochat.ai/papers/10.1212/wnl.0000000000002401
The paper
Odekerken, V. J. J., Boel, J. A., Schmand, B. A., de Haan, R. J., Figee, M., van den Munckhof, P., Schuurman, P. R., de Bie, R. M. A., For the NSTAPS study group, NSTAPS study group, de Bie, R. M. A., Bour, L., Contarino, M. F., de Haan, R. J., Iwan, M., Mink, M. S. J., van den Munckhof, P., Odekerken, V. J. J., Postma, M., . . . van Vugt, J. P. P. (2016). GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up. Neurology. https://doi.org/10.1212/wnl.0000000000002401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.